Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2005 1
2006 1
2008 1
2009 1
2011 1
2014 1
2017 1
2019 1
2020 1
2021 2
2022 5
2023 3
2024 3
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Humoral response to SARS-CoV-2 mRNA vaccine in patients with multiple sclerosis treated with natalizumab.
Capuano R, Donnarumma G, Bisecco A, Grimaldi E, Conte M, d'Ambrosio A, Matrone F, Risi M, Borgo RM, Altieri M, Giuliano F, Coppola N, Galdiero M, Tedeschi G, Gallo A. Capuano R, et al. Among authors: grimaldi e. Ther Adv Neurol Disord. 2021 Aug 13;14:17562864211038111. doi: 10.1177/17562864211038111. eCollection 2021. Ther Adv Neurol Disord. 2021. PMID: 34413902 Free PMC article. No abstract available.
Varicocoele embolization with sclerosing agents leads to lower radiation exposure and procedural costs than coils: Data from a real-life before and after study.
Boeri L, Fulgheri I, Cristina M, Biondetti P, Rossi S, Grimaldi E, Lucignani G, Gadda F, Ierardi AM, Salonia A, Viganò P, Somigliana E, Carrafiello G, Montanari E. Boeri L, et al. Among authors: grimaldi e. Andrology. 2022 May;10(4):694-701. doi: 10.1111/andr.13162. Epub 2022 Feb 26. Andrology. 2022. PMID: 35179316 Free PMC article.
Humoral response and safety of the third booster dose of BNT162b2 mRNA COVID-19 vaccine in patients with multiple sclerosis treated with ocrelizumab or fingolimod.
Capuano R, Altieri M, Conte M, Bisecco A, d'Ambrosio A, Donnarumma G, Grimaldi E, Coppola N, Medici N, Galdiero M, Tedeschi G, Gallo A. Capuano R, et al. Among authors: grimaldi e. J Neurol. 2022 Dec;269(12):6185-6192. doi: 10.1007/s00415-022-11296-4. Epub 2022 Jul 26. J Neurol. 2022. PMID: 35879563 Free PMC article.
22 results